Xencor, Inc. (XNCR)
12.38
-0.06
(-0.48%)
USD |
NASDAQ |
May 13, 16:00
12.41
+0.03
(+0.24%)
After-Hours: 06:46
Xencor Free Cash Flow : -188.84M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rigel Pharmaceuticals, Inc. | 79.27M |
| Ultragenyx Pharmaceutical, Inc. | -507.20M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -67.63M |
| Cash from Investing (Quarterly) | 26.68M |
| Cash from Financing (Quarterly) | 0.95M |
| Free Cash Flow Per Share (Quarterly) | -0.9069 |
| Free Cash Flow to Equity (Quarterly) | -55.66M |
| Free Cash Flow to Firm (Quarterly) | -63.53M |
| Free Cash Flow Yield | -20.44% |